These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8516812)

  • 1. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue.
    Nishiyama R; Nakamura S; Suzuki S; Baba S
    Transplantation; 1993 Jun; 55(6):1261-5. PubMed ID: 8516812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion.
    Suzuki S; Serizawa A; Sakaguchi T; Tsuchiya Y; Kojima Y; Okamoto K; Kurachi K; Konno H; Fujise Y; Baba S; Nakamura S
    Transplantation; 2000 Jun; 69(11):2267-73. PubMed ID: 10868624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet activating factor as a pivotal mediator of shock after liver ischemia.
    Fukuoka T; Nakajima Y; Nakano H
    Surg Today; 1995; 25(4):351-6. PubMed ID: 7633127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1.
    Qayumi AK; English JE; Duncan S; Ansley DM; Pearson B; Nikbakht-Sangari M; Sammartino C; Fradet G
    J Heart Lung Transplant; 1997 Sep; 16(9):946-55. PubMed ID: 9322146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
    Yin M; Buurman WA; Daemen JW; Kootstra G
    Transplantation; 1996 May; 61(10):1443-6. PubMed ID: 8633367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury.
    Yin M; Kurvers HA; Buurman WA; Tangelder GJ; Booster MH; Daemen JH; Kondracki S; Kootstra G
    Transplant Proc; 1995 Feb; 27(1):774-6. PubMed ID: 7879180
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
    Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
    Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
    Stammberger U; Carboni GL; Hillinger S; Schneiter D; Weder W; Schmid RA
    J Heart Lung Transplant; 1999 Sep; 18(9):862-8. PubMed ID: 10528748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury.
    Yin M; Kurvers HA; Buurman WA; Tangelder GJ; Tiebosch AT; Daemen JH; Kootstra G
    Transplant Proc; 1995 Oct; 27(5):2844-6. PubMed ID: 7482939
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.
    Katoh S; Toyama J; Kodama I; Koike A; Abe T
    Cardiovasc Res; 1993 Aug; 27(8):1430-4. PubMed ID: 8221795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver.
    Kim YI; Kai T; Kitano S; Ishii T; Tatsuma T; Kamada N; Sugimachi K
    Transplantation; 1994 Oct; 58(8):875-9. PubMed ID: 7940729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet-activating factor antagonist on brain injury in rats.
    Tokutomi T; Sigemori M; Kikuchi T; Hirohata M
    Acta Neurochir Suppl (Wien); 1994; 60():508-10. PubMed ID: 7976632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.
    Murohisa G; Kobayashi Y; Kawasaki T; Nakamura S; Nakamura H
    Liver; 2002 Oct; 22(5):394-403. PubMed ID: 12390475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.